Glenmark Pharmaceuticals Investor Relations Material
Latest events
Q4 24/25
Glenmark Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Glenmark Pharmaceuticals Ltd
Access all reports
Glenmark Pharmaceuticals Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of generic and specialty medicines. The company operates across multiple therapeutic areas, including dermatology, respiratory, oncology, and cardiovascular diseases. The company is headquartered in Mumbai, India, and its shares are listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE).
Key slides for Glenmark Pharmaceuticals Ltd
Q4 24/25
Glenmark Pharmaceuticals Ltd
Q3 24/25
Glenmark Pharmaceuticals Ltd
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
GLENMARK
Country
🇮🇳 India